Understanding the symptoms of cirrhosis can facilitate early diagnosis and intervention, improving outcomes for those ...
EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, announced positive results from its phase 1b IMPuLCE study ...
Liver cancer is a significant global health issue, and its early detection plays a crucial role in improving patient outcomes ...
Fatty liver disease happens when fat builds up in your liver. This can cause damage, inflammation, and other complications.
Complete 3-year clinical data from the MATCH Phase 2 study demonstrate long-term efficacy and safety with autologous, non-engineered macrophages in patients with advanced liver cirrhosis. – New ...
A fatty liver can cause a number of health problems such as liver damage, cancer, stroke, diabetes, kidney disease and ...
In addition to their ongoing community work, the team will host a Liver Health Check event in Scunthorpe on January 31. Local ...
EBX-102 demonstrated proof-of-principle across multiple microbiome assessments, inflammatory biomarkers and clinical assessments, supporting its cont ...
Liver cirrhosis is irreversible damage or scarring to the liver as a result of advanced liver disease (such as hepatitis) that stops the liver functioning, potentially leading to liver failure.
Cirrhosis is the leading cause of liver transplantation ... Highly Skilled Surgeons and Healthcare Professionals: India has a ...
The active agent is approved in the U.S. and in about 40 countries for related complications of advanced liver cirrhosis. For more information, visit www.bioviepharma.com ...
Favorable capital market conditions last week enabled the company to raise over $15 million from secondary offerings, and the proceeds allow the Company to fund fully the costs of this upcoming ...